Clinical evaluation of CT-guided percutaneous microwave ablation of non-small cell lung cancer
Tao XIE,Jun XU,Xian-hai ZHU,Han-lin QIN,Lei ZHOU,Yi-peng FEI,Chang-gao SHI,Wei-yu WANG
DOI: https://doi.org/10.3969/j.issn.1005-8001.2017.04.010
2017-01-01
Abstract:Objective To investigate the clinical efficacy and safety of CT-guided percutaneous microwave ablation (PMAT) in the treatment of non-small cell lung cancer (NSCLC). Methods 36 patients with NSCLC were divided according to the diame-ters of the tumor masses into small (<3 cm, 19 patients), medium (3-5 cm, 11), and large (>5 cm, 6) groups. The curative effect of local tumor was evaluated using RECIST standard and the survival time was calculated by Kaplan-Meier method after 3-50 month follow-up. The survival rates of patients with different tumor diameters were compared at 1, 2, 3 and 4 years after PMAT. Results All 36 patients underwent PMAT successfully without serious complications. The local tumor progression rate was 27.8％ in the me-dian follow-up of 24 months without significant difference (χ2=0.036, P=0.850) between the small (21.5％) and medium (21.7％) groups. The tumor progression rate of the large group was significantly higher than that of small (χ2=4.360,P=0.037) and medium (χ2=3.996, P=0.046) groups. The median survival time was 27 months for all patients, 36 months for the small and medium groups, and 15 months for the large group. The overall survival rates were 83.3％, 55.6％, 36.1％, and 19.4％ in 1-4 years, respectively. There was no significant difference (χ2=0.045, P=0.832) in survival rates of small (89.5％, 63.2％, 47.4％, 26.3％) and medium groups (81.8％, 54.5％, 45.5％, 22.7％) at 1-4 years. The survival rates at 1 (χ2=7.858, P=0.005) and 2 (χ2=4.494, P=0.034) years of the large group were significantly lower than the small and medium groups. At 1 month after PMAT, there was no patient death, intracavitary bleeding, bleeding or tumor seeding along the needle track. Ablation syndrome was the most common complica-tion (9 patients), followed by local pain and heat (7), and small pneumothorax (4). Conclusion CT-guided PMAT is effective and safe as the first-line treatment of patients with NSCLC smaller than 5 cm.